A Phase l/ll trial of Trabedersen for pancreatic cancer.
Phase of Trial: Phase I/II
Latest Information Update: 27 Sep 2016
At a glance
- Drugs Trabedersen (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions
- 27 Sep 2016 New trial record
- 02 Sep 2016 Results from this trial will be presented at the 43rd International Society of Oncology and Biomarkers (ISOBM) Congress 2016, as reported by an Oncotelic media release.